USB252947I5 - - Google Patents

Info

Publication number
USB252947I5
USB252947I5 US25294772A USB252947I5 US B252947 I5 USB252947 I5 US B252947I5 US 25294772 A US25294772 A US 25294772A US B252947 I5 USB252947 I5 US B252947I5
Authority
US
United States
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to US252947A priority Critical patent/US3923803A/en
Publication of USB252947I5 publication Critical patent/USB252947I5/en
Application granted granted Critical
Publication of US3923803A publication Critical patent/US3923803A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80Oxygen atoms
    • C07D239/82Oxygen atoms with an aryl radical attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
US252947A 1968-07-18 1972-05-12 2(1H)-Quinozalinones and process therefor Expired - Lifetime US3923803A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US252947A US3923803A (en) 1968-07-18 1972-05-12 2(1H)-Quinozalinones and process therefor

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP5098268 1968-07-18
JP5098368 1968-07-18
JP7637768 1968-10-18
US84085669A 1969-07-10 1969-07-10
US252947A US3923803A (en) 1968-07-18 1972-05-12 2(1H)-Quinozalinones and process therefor

Publications (2)

Publication Number Publication Date
USB252947I5 true USB252947I5 (en) 1975-01-28
US3923803A US3923803A (en) 1975-12-02

Family

ID=27522920

Family Applications (1)

Application Number Title Priority Date Filing Date
US252947A Expired - Lifetime US3923803A (en) 1968-07-18 1972-05-12 2(1H)-Quinozalinones and process therefor

Country Status (1)

Country Link
US (1) US3923803A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258187A (en) * 1977-06-16 1981-03-24 E. I. Du Pont De Nemours And Company Process for preparing quinazolinone oxides
AR038658A1 (en) * 2001-06-15 2005-01-26 Novartis Ag DERIVATIVES OF 4-ARIL-2 (1H) QUINAZOLINONA AND 4-ARIL-QUINAZOLINA 2-SUBSTITUTES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF A MEDICINAL PRODUCT

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1520743A (en) * 1966-12-02 1968-04-12 Roussel Uclaf Novel substituted quinazolinones and method of preparation
US3723432A (en) * 1968-11-12 1973-03-27 Sandoz Ag 1-substituted-4-aryl-2(1h)-quinazolinones and their preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1520743A (en) * 1966-12-02 1968-04-12 Roussel Uclaf Novel substituted quinazolinones and method of preparation
US3723432A (en) * 1968-11-12 1973-03-27 Sandoz Ag 1-substituted-4-aryl-2(1h)-quinazolinones and their preparation

Also Published As

Publication number Publication date
US3923803A (en) 1975-12-02

Similar Documents

Publication Publication Date Title
FR2024830B1 (en)
AU1946070A (en)
AU428130B2 (en)
AU2374870A (en)
AU5184069A (en)
AU6168869A (en)
FR2013172B1 (en)
AU429879B2 (en)
AU416157B2 (en)
USB252947I5 (en)
AU2581067A (en)
AU4811568A (en)
AU421558B1 (en)
RO57329A (en)
AU3789668A (en)
AU2580267A (en)
AU4744468A (en)
AR203075Q (en)
AU3224368A (en)
AU463027A (en)
AU4464266A (en)
AU4503667A (en)
AU4558658A (en)
AU4270368A (en)
BE728323A (en)